Interview with:
Paul M. Walker, M.D., Ph.D., F.R.C.S.C, Director, President and CEO - featuring: their
diagnostics products that enable clinicians to institute appropriate treatment in a manner
of minutes; their Sepsis assay the EAA is the first FDA approved assay for the early
diagnosis of sepsis, one of the major health care challenges worldwide. |
CEOCFO-Members Login
Become A Member!
|
This is a printer friendly page!
Spectral Diagnostics is
establishing a distribution network in Europe with companies who have focused in the area
of sepsis and blood purification and are capable of properly representing their diagnostic
products to clinicians
![wpe11.jpg (3611 bytes)](SDI-Sp1.jpg)
Healthcare
Disease Management
(SDI-TSX)
Spectral Diagnostics Inc.
![wpe1A.jpg (11530 bytes)](SDI-Sp2.jpg)
Paul M. Walker, M.D., Ph.D., F.R.C.S.C
Director, President and CEO
Interview conducted by:
Lynn Fosse, Senior Editor
CEOCFOinterviews.com
Published - April 12, 2007
![wpe20.jpg (13926 bytes)](member2.jpg)
disclaimers
Any reproduction or further distribution of this
article without the express written consent of CEOCFOinterviews.com is prohibited.
|
With
respect to our Endotoxin Activity Assay the EAA, we have a joint arrangement with
Toray Medical Products a division of Toray Industries, Inc. in Japan. We are establishing
a distribution network within Europe. We have concluded agreements in Italy and Spain and
we are looking to conclude distribution agreements for the rest of Europe in the very near
future. These distribution companies have been carefully chosen and are focused in the
area of sepsis, blood purification etc., and are capable of distributing our product
properly and representing it properly to the clinicians who will be in the position of
ordering this. A lot of our marketing takes place with the presentation of our clinical
data, which we have gathered over the past couple of years from clinical trials. We have
been doing this around the world at a number of different centers. We have 7 or 8 in the United
States, several more in Europe etc.; we are quite global in our opinion leader
support. - Paul M. Walker, M.D., Ph.D., F.R.C.S.C |